|
|
||||||||
The FASEB Journal, Vol 11, 851-857, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
G Leonarduzzi, A Scavazza, F Biasi, E Chiarpotto, S Camandola, S Vogel, R Dargel and G Poli
Department of Experimental Medicine and Oncology, University of Torino, Italy.
An increasing number of reports underscore the frequent association of fibrosclerotic diseases of lung, liver, arterial wall, brain, etc., with the accumulation of oxidatively modified lipids and proteins. A cause-and-effect relationship has been proposed between cellular oxidative damage and increased fibrogenesis based on the fact that experimental treatment with antioxidants either prevents or quenches the fibrotic process. With some peculiarities in the different organs, fibrosclerosis is essentially the result of the interaction of macrophages and extracellular matrix-producing cells. The cross-talk is mediated by fibrogenic cytokines, among which the most important appears to be transforming growth factor beta1 (TGF-beta1). This report describes treatment of different types of macrophage, of both human and murine origin, with 4-hydroxy-2,3-nonenal (HNE) a major aldehyde end product of membrane lipid oxidation found consistently to induce both mRNA expression and synthesis of TGF-beta1. Since increased HNE levels have been demostrated in the cirrhotic liver and in the oxidatively modified low-density human lipoproteins associated with atherosclerosis, the up-regulation of macrophage TGF-beta1 by HNE appears to be involved in the pathogenesis of these and similar diseases characterized by fibrosclerosis.
This article has been cited by other articles:
![]() |
K. G. Tolman, V. Fonseca, A. Dalpiaz, and M. H. Tan Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease Diabetes Care, March 1, 2007; 30(3): 734 - 743. [Full Text] [PDF] |
||||
![]() |
B. P. Sampey, B. J. Stewart, and D. R. Petersen Ethanol-induced Modulation of Hepatocellular Extracellular Signal-regulated Kinase-1/2 Activity via 4-Hydroxynonenal J. Biol. Chem., January 19, 2007; 282(3): 1925 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, X. Chen, Q. Hong, H. Lin, H. Zhu, Q. Liu, J. Wang, Y. Xie, X. Shang, S. Shi, et al. TIMP-1 Promotes Age-Related Renal Fibrosis Through Upregulating ICAM-1 in Human TIMP-1 Transgenic Mice J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2006; 61(11): 1130 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yozai, K. Shikata, M. Sasaki, A. Tone, S. Ohga, H. Usui, S. Okada, J. Wada, R. Nagase, D. Ogawa, et al. Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3326 - 3338. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, K. Saito, E. Noiri, M. Sata, H. Ikeda, A. Ohno, J. Ando, I. Mori, M. Ohno, and R. Nagai Administration of ANG II induces iron deposition and upregulation of TGF-{beta}1 mRNA in the rat liver Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1063 - R1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, N. Ishizaka, T. Aizawa, M. Sata, N. Iso-o, E. Noiri, I. Mori, M. Ohno, and R. Nagai Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-{beta}1 in the heart Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1836 - H1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Tolman, V. Fonseca, M. H. Tan, and A. Dalpiaz Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus Ann Intern Med, December 21, 2004; 141(12): 946 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Absood, A. Furutani, T. Kawamura, and L. M. Graham A comparison of oxidized LDL-induced collagen secretion by graft and aortic SMCs: role of PDGF Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1200 - H1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhong, M. Froh, M. Lehnert, R. Schoonhoven, L. Yang, H. Lind, J. J. Lemasters, and R. G. Thurman Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G1004 - G1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okada, K. Shikata, M. Matsuda, D. Ogawa, H. Usui, Y. Kido, R. Nagase, J. Wada, Y. Shikata, and H. Makino Intercellular Adhesion Molecule-1-Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes Diabetes, October 1, 2003; 52(10): 2586 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Card, W. J. Racz, J. F. Brien, and T. E. Massey Attenuation of Amiodarone-Induced Pulmonary Fibrosis by Vitamin E Is Associated with Suppression of Transforming Growth Factor-beta 1 Gene Expression but Not Prevention of Mitochondrial Dysfunction J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rahman, A. A. M. van Schadewijk, A. J. L. Crowther, P. S. Hiemstra, J. Stolk, W. MacNee, and W. I. De Boer 4-Hydroxy-2-Nonenal, a Specific Lipid Peroxidation Product, Is Elevated in Lungs of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 490 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Trinder, C Fox, G Vautier, and J K Olynyk Molecular pathogenesis of iron overload Gut, August 1, 2002; 51(2): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Angulo Nonalcoholic Fatty Liver Disease N. Engl. J. Med., April 18, 2002; 346(16): 1221 - 1231. [Full Text] [PDF] |
||||
![]() |
F Biasi, L Tessitore, D Zanetti, J C Cutrin, B Zingaro, E Chiarpotto, N Zarkovic, G Serviddio, and G Poli Associated changes of lipid peroxidation and transforming growth factor {beta}1 levels in human colon cancer during tumour progression Gut, March 1, 2002; 50(3): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hattori, S. Hattori, and K. Kasai 4-Hydroxynonenal Prevents NO Production in Vascular Smooth Muscle Cells by Inhibiting Nuclear Factor-{kappa}B-Dependent Transcriptional Activation of Inducible NO Synthase Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1179 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dworski Oxidant stress in asthma Thorax, October 1, 2000; 55(90002): 51S - 53. [Full Text] |
||||
![]() |
R. Smyth Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure Thorax, August 1, 2000; 55(90001): S51 - 55. [PDF] |
||||
![]() |
E. Lutgens, K. B. J. M. Cleutjens, S. Heeneman, V. E. Koteliansky, L. C. Burkly, and M. J. A. P. Daemen Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype PNAS, June 20, 2000; 97(13): 7464 - 7469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roman, A. Gimenez, J. M. Lluis, M. Gasso, M. Rubio, J. Caballeria, A. Pares, J. Rodes, and J. C. Fernandez-Checa Enhanced DNA Binding and Activation of Transcription Factors NF-kappa B and AP-1 by Acetaldehyde in HEPG2 Cells J. Biol. Chem., May 5, 2000; 275(19): 14684 - 14690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lonigro, D. Donnini, D. Fabbro, G. Perrella, G. Damante, F. S. Ambesi Impiombato, and F. Curcio Thyroid-Specific Gene Expression Is Differentially Influenced by Intracellular Glutathione Level in FRTL-5 Cells Endocrinology, March 1, 2000; 141(3): 901 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. DWORSKI, J. J. MURRAY, L. JACKSONROBERTS II, J. A. OATES, J. D. MORROW, L. FISHER, and J. R. SHELLER Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics . Evidence for Oxidant Stress Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1947 - 1951. [Abstract] [Full Text] |
||||
![]() |
T. MIYATA, S. SUGIYAMA, M. NANGAKU, D. SUZUKI, K.-I. URAGAMI, R. INAGI, H. SAKAI, and K. KUROKAWA Apolipoprotein E2/E5 Variants in Lipoprotein Glomerulopathy Recurred in Transplanted Kidney J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1590 - 1595. [Abstract] [Full Text] |
||||
![]() |
A. Bobik, A. Agrotis, P. Kanellakis, R. Dilley, A. Krushinsky, V. Smirnov, E. Tararak, M. Condron, and G. Kostolias Distinct Patterns of Transforming Growth Factor-ß Isoform and Receptor Expression in Human Atherosclerotic Lesions : Colocalization Implicates TGF-ß in Fibrofatty Lesion Development Circulation, June 8, 1999; 99(22): 2883 - 2891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Page, C. Fischer, B. Baumgartner, M. Haas, U. Kreusel, G. Loidl, M. Hayn, H. W. L. Ziegler-Heitbrock, D. Neumeier, and K. Brand 4-Hydroxynonenal Prevents NF-{kappa}B Activation and Tumor Necrosis Factor Expression by Inhibiting I{kappa}B Phosphorylation and Subsequent Proteolysis J. Biol. Chem., April 23, 1999; 274(17): 11611 - 11618. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. SUZUKI, T. MIYATA, N. SAOTOME, K. HORIE, R. INAGI, Y. YASUDA, K. UCHIDA, Y. IZUHARA, M. YAGAME, H. SAKAI, et al. Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions J. Am. Soc. Nephrol., April 1, 1999; 10(4): 822 - 832. [Abstract] [Full Text] |
||||
![]() |
K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation. 4-HYDROXY-2-NONENAL IS A POTENTIAL INDUCER OF INTRACELLULAR PEROXIDE PRODUCTION J. Biol. Chem., January 22, 1999; 274(4): 2234 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-M. Liu, L. Gao, J. Choi, and H. J. Forman gamma -Glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L861 - L869. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Factor, A. Kiss, J. T. Woitach, P. J. Wirth, and S. S. Thorgeirsson Disruption of Redox Homeostasis in the Transforming Growth Factor-alpha /c-myc Transgenic Mouse Model of Accelerated Hepatocarcinogenesis J. Biol. Chem., June 19, 1998; 273(25): 15846 - 15853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |